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Incubation of rat adipocytes with the phorbol ester TPA caused a dose-dependent, persistent increase in 
phosphatidate phosphohydrolase activity and decrease in fatty acyl-CoA synthetase activity. Half-maximal 
effects were obtained with l-2 x lO-‘O M TPA. TPA did not alter basal or noradrenaline-stimulated lipoly- 
sis. It is suggested that these two enzymes might be modified by protein kinase C. 
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1. INTRODUCTION 
12-0-Tetradecanoylphorbol 13-acetate (TPA) is 
the most potent of a series of phorbol diesters 
which are well known tumour promoters. Recent 
studies have provided evidence that a Ca2+- and 
phospholipid-dependent protein kinase, protein 
kinase C, is a target for phorbol esters as the 
tumour promoters activate this enzyme both in 
vitro and in vivo [ 11. TPA and other phorbol esters 
appear to stimulate protein kinase C by 
substituting for diacylglycerol which is required to 
activate the enzyme [2]. Structure-activity studies 
show good correlation between the ability of in- 
dividual phorbol esters to promote tumours and to 
activate protein kinase C. The observed effects of 
TPA in a variety of cell types are extremely diverse 
but these include rapid effects which may relate to 
lipid and carbohydrate metabolism. For example, 
TPA causes inactivation of glycogen synthase in 
hepatocytes [3] and protein kinase C phosphory- 
lates and inactivates liver and muscle glycogen 
synthase [4]. Furthermore, TPA increases the 
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phosphorylation of hepatocyte cytosolic proteins 
whose phosphorylation is also increased by angio- 
tensin II or vasopressin [5]. Other effects include 
stimulation of phospholipid synthesis [a], stimula- 
tion of 2-deoxyglucose oxidation [7], diminished 
elevation of cyclic AMP levels in response to 
glucagon [8] or P-adrenergic stimulation [9], 
diminution of the affinity of epidermal~growth fac- 
tor or insulin binding to receptors [lo-121 and in- 
creased phosphorylation of these receptors [13,141. 
Since protein kinase C is reported to be present 
in rat adipose tissue [ 15-171 we have investigated 
the effect of brief exposure of adipocytes to TPA 
on the activities of two enzymes in the 
triacylglycerol synthesis pathway. Both enzymes, 
Mg2+-dependent phosphatidate phosphohydrolase 
(PPH, EC 3.1.3.4) and ATP-dependent fatty acyl- 
CoA synthetase (FAS, EC 6.2.1.3), may play a role 
in the regulation of triacylglycerol synthesis in 
adipose tissue and appear to exist in different ac- 
tivity states that are subject to rapid interconver- 
sion in response to hormones. For example, PPH 
in adipocytes is regulated by noradrenaline and in- 
sulin [18-201 and the hepatocyte enzyme is ac- 
tivated by vasopressin [21]. Likewise, FAS in 
Published by Elsevier Science Publishers B. V. (Biomedical Division) 
00145793/85/$3.30 8 1985 Federation of European Biochemical Societies 351 
Volume 179, number 2 FEBS LETTERS January 1985 
adipose tissue is regulated by insulin, catechol- 
amine hormones and corticotropin [21-251. The 
mechanisms underlying these activity changes are 
unknown at present. 
2. MATERIALS AND METHODS 
Chemicals were obtained and treated as in 
[18,19,23,25]. In addition, TPA and 12-0- 
tetradecanoylphorbol 13-acetate 4-O-methyl ether 
were obtained from Sigma (London). Epididymal 
fat pads from fed male rats (170-190 g) were used 
as the source of adipocytes [26]. Adipocytes 
equivalent o 2/3 of a fat pad were incubated for 
30 min in siliconised 25ml flasks with shaking at 
37°C under 02 + CO2 (95:5%). All flasks con- 
tained 4 ml Krebs-Ringer bicarbonate, albumin 
(40 mg/ml), 5 mM glucose, adenosine deaminase 
(4 munits/ml), 0.35 mM dimethyl sulphoxide 
(DMSO) and various additions of phorbol esters or 
noradrenaline. After 30 min the cells were 
separated from the incubation medium by cen- 
trifugation and frozen in liquid Nz [ 181. Samples of 
incubation media were saved for measurement of 
glycerol [27]. 
Extracts from frozen adipocytes were prepared 
by homogenization in 1.0 ml ice-cold 0.25 M 
sucrose medium containing 1 mM EDTA, 1 mM 
dithiothreitol, 10 mM Tris-HCl (pH 7.4) in an 
Ultra-Turrax homogeniser for 3 x 10-s periods 
with 10-s intervals. The extracts were centrifuged 
for 1 min in an Eppendorf 5412 centrifuge and the 
resulting fat-free homogenate used for enzyme 
assays. 
Lactate dehydrogenase (EC 1.1.1.27) was 
assayed as in [28]. PPH was assayed as Pi release 
from phosphatidate as in [18]. FAS activity was 
assayed by following the incorporation of 
[3H]palmitate into [3H]palmitoyl-CoA [22,25]. 
Both PPH and FAS activities are expressed as 
nmol product produced/min per unit lactate 
dehydrogenase activity. Lactate dehydrogenase is 
unaffected by treatment of cells with 
noradrenaline or phorbol esters and therefore this 
form of expression corrects for any incompleteness 
of cell breakage and recovery during homo- 
genization. 
Statistical significance was determined by Stu- 
dent’s t-test for paired samples. Throughout values 
are presented as means -+ SE. 
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3. RESULTS AND DISCUSSION 
Adipocytes were incubated for 30 min with a 
range of TPA concentrations which were added 
with 0.35 mM DMSO. Although this addition 
changed the basal activity of FAS from 32 * 4 to 
40 + 4 (n = 6) and that of PPH from 35 + 5 to 
33 + 5 (n = 5), these effects of the solvent were not 
statistically significant. Fig. 1 shows that TPA 
brought about a dose-dependent increase in PPH 
activity and a decrease in FAS activity. In both 
cases the maximum change (+ 35% for PPH and 
-28% for FAS) was seen with lo-’ M TPA and 
half-maximal effects were observed at approx. 
l-2 x lo-” M TPA which is similar to, or lower 
than, the concentrations of TPA exerting half- 
maximal effects in other systems [1,3,4,8,1 l-131. 
As a control experiment, the 4-O-methyl ether of 
TPA, which is not a tumour promoter, was tested 
at a concentration of lo-’ M in 4 separate 
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Fig.1. Effect of TPA concentration on PPH and FAS 
activities. Adipocytes were incubated as described in 
section 2 for 30 min with the indicated concentrations of 
TPA. The activities are means f SE of 4-5 separate 
experiments in every case and are expressed as nmol/min 
per unit lactate dehydrogenase. For FAS all changes in 
activity are significant to the level of P < 0.05 over the 
TPA concentration range 5 x lo-” M - 5 x lo-’ M. 
For PPH all changes in activity are significant to the 
level of P < 0.025 over the TPA concentration range 5 x 
lo-” - lo-’ M. (0) PPH, (0) FAS. 
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adipocyte preparations and was found to be inef- 
fective (a 2 + 2% increase in PPH and a 1 + 2% 
decrease in FAS activity were observed). Parallel 
incubations of cells with 10e6 M noradrenaline 
were performed. This treatment resulted in a 56 f 
8% decrease in FAS activity (n = 6) and 20 + 8(‘10 
decrease in PPH activity (n = 4) in accord with 
previous findings [18-20,23,25]. The decrease in 
FAS activity caused by noradrenaline was there- 
fore approximately double that caused by the 
maximally effective dose of TPA. Incubation of 
cells with 10m6 M noradrenaline + 5 x lo-’ M 
TPA resulted in a 52 -+ 2% decrease in FAS ac- 
tivity, i.e., the effects of the two agents on this ac- 
tivity were non-additive. Addition of 10e6 M 
noradrenaline to cells incubated with lo-’ M TPA 
resulted in a 38 f 5% decrease in PPH activity 
compared with incubations with TPA alone, i.e., 
noradrenaline appeared to override the stimulatory 
effects of TPA on this activity and TPA slightly 
enhanced the inactivating effect of noradrenaline. 
Glycerol accumulation in incubation media was 
measured as an index of lipolysis. Basal lipolysis 
resulted in 0.05 + 0.00 mM glycerol in incubation 
media after 30 min. TPA (5 x lo-” - 5 x lo-’ M) 
did not increase lipolysis above the basal rate. 
1 0e6 M noradrenaline raised the glycerol release to 
0.84 + 0.06 mM. Lipolysis in the presence of 
10e6 M noradrenaline + 5 x lo-’ M TPA was not 
significantly different from that in the presence of 
noradrenaline alone. The phorbol ester therefore 
does not appear to modify the activity state of the 
hormone-sensitive lipase. 
It is concluded that FAS and PPH, or un- 
characterized systems regulating their activity, may 
be modified by the action of protein kinase C pre- 
sent in adipocytes. In the physiological setting pro- 
tein kinase C could be stimulated by diacylglycerol 
arising from phosphoinositide breakdown. In the 
rat adipocyte this is probably increased by 
ai-adrenergic stimulation [29,30] and possibly by 
insulin [30-321. At present no coherent picture 
emerges ince both FAS and PPH are decreased by 
noradrenaline and these effects are opposed by in- 
sulin [19,25]. However, it is noteworthy that the 
increase in PPH activity seen in this study with 
TPA is matched by a comparable increase in PPH 
activity when hepatocytes are incubated with 
vasopressin [21] - a hormone likely to activate 
protein kinase C in hepatocytes [5,33]. 
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